{"id":47016,"date":"2018-09-22T01:00:00","date_gmt":"2018-09-26T01:35:10","guid":{"rendered":"http:\/\/www.05921.net\/index.php\/2018\/09\/26\/hif-%e4%ba%8c%e6%b0%a7%e9%85%b6%e6%8a%91%e5%88%b6%e5%89%82%e6%9c%89%e6%9c%9b%e8%ae%a9%e8%82%be%e7%97%85%e7%bb%bc%e5%90%88%e5%be%81%e6%82%a3%e8%80%85%e9%99%8d%e4%bd%8e%e5%af%b9%e4%bf%83%e7%ba%a2\/"},"modified":"2018-09-26T09:35:12","modified_gmt":"2018-09-26T01:35:12","slug":"hif-%e4%ba%8c%e6%b0%a7%e9%85%b6%e6%8a%91%e5%88%b6%e5%89%82%e6%9c%89%e6%9c%9b%e8%ae%a9%e8%82%be%e7%97%85%e7%bb%bc%e5%90%88%e5%be%81%e6%82%a3%e8%80%85%e9%99%8d%e4%bd%8e%e5%af%b9%e4%bf%83%e7%ba%a2","status":"publish","type":"post","link":"https:\/\/www.05921.net\/index.php\/47016\/","title":{"rendered":"HIF-\u4e8c\u6c27\u9176\u6291\u5236\u5242\u6709\u671b\u8ba9\u80be\u75c5\u7efc\u5408\u5f81\u60a3\u8005\u964d\u4f4e\u5bf9\u4fc3\u7ea2\u7d20\u7684\u4f9d\u8d56"},"content":{"rendered":"<div class=\"bpp-post-content\">\n<p style=\"text-align: justify;margin-bottom: 10px;\"><span style=\"font-size: 15px;\">\u8fd1\u65e5\uff0c\u5b89\u65af\u6cf0\u6765\u516c\u544a\u79f0\u5176\u5728\u7814\u65b0\u836fRoxadustat\uff08\u7f57\u6c99\u53f8\u4ed6\uff09\u5728\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u8fbe\u5230\u4e3b\u8981\u7ec8\u70b9\uff0c\u524d24\u5468\u300128\u5468\u548c52\u5468\u7684\u8840\u7ea2\u86cb\u767d\u5e94\u7b54\u7387\u76f8\u6bd4\u57fa\u7ebf\u6709\u663e\u8457\u6027\u5dee\u5f02\u3002\u867d\u7136\u5b89\u65af\u6cf0\u6765\u6ca1\u6709\u516c\u5e03\u5177\u4f53\u6570\u636e\uff0c\u4f46\u4ece\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6765\u770b\uff0c\u8fd9\u4e2a\u836f\u7269\u662f\u975e\u5e38\u6709\u6f5c\u529b\u7684\u3002\u56e0\u4e3a\u6162\u6027\u80be\u75c5\u7efc\u5408\u5f81\u5f15\u8d77\u7684\u8d2b\u8840\u6cbb\u7597\u65b9\u6848\u7f3a\u4e4f\uff0c\u76ee\u524d\u53ea\u80fd\u4f7f\u7528\u4fc3\u7ea2\u7d20\u6cbb\u7597\uff0c\u5982\u672c\u54c1\u83b7\u6279\uff0c\u6709\u671b\u8ba9\u80be\u75c5\u7efc\u5408\u5f81\u60a3\u8005\u964d\u4f4e\u5bf9\u4fc3\u7ea2\u7d20\u7684\u4f9d\u8d56\u3002<\/span><\/p>\n<p style=\"text-align: justify;margin-bottom: 10px;\"><span style=\"font-size: 15px;\">Roxadustat \u662f\u4e00\u79cd\u65b0\u578b\u7684\u53e3\u670d\u4f4e\u6c27\u8bf1\u5bfc\u56e0\u5b50\u812f\u6c28\u9170\u7f9f\u5316\u9176\u6291\u5236\u5242\uff0c\u53ef\u8bf1\u5bfc\u5185\u6e90\u6027\u7ea2\u7ec6\u80de\u751f\u6210\u7d20\u5347\u9ad8\uff0c\u4fc3\u8fdb\u7ea2\u7ec6\u80de\u751f\u6210\uff0c\u56e0\u6b64\u53ef\u4ee5\u7528\u4f5c\u6162\u6027\u80be\u810f\u75be\u75c5\u60a3\u8005\u8d2b\u8840\u6cbb\u7597\u30022017 \u5e74 10 \u6708 31 \u65e5\uff0c\u5b89\u65af\u6cf0\u6765\u548c FibroGen \u516c\u5f00\u4e00\u9879\u8bc4\u4f30 Roxadustat \u6cbb\u7597\u6162\u6027\u80be\u810f\u75be\u75c5\uff08CKD\uff09\u8d2b\u8840\u60a3\u8005\u7684 III \u671f\u4e34\u5e8a\u8bd5\u9a8c\u6570\u636e\u300243 \u540d\u66fe\u63a5\u53d7\u6216\u672a\u63a5\u53d7\u7ea2\u7ec6\u80de\u751f\u6210\u4fc3\u8fdb\u5242\u6cbb\u7597\u7684\u65e5\u672c\u8179\u819c\u900f\u6790\u60a3\u8005\uff0c\u5728 18 \u81f3 24 \u5468\u90fd\u8868\u73b0\u51fa\u79ef\u6781\u7684\u7597\u6548\u6570\u636e\u3002\u7ed3\u679c\u663e\u793a\uff0cRoxadustat \u8010\u53d7\u6027\u826f\u597d\uff0c\u63a5\u53d7\u8fc7\u548c\u672a\u63a5\u53d7\u5148\u524d\u4fc3\u7ea2\u7ec6\u80de\u751f\u6210\u5242\u6cbb\u7597\u7684\u60a3\u8005\u5747\u5b9e\u73b0\u7ef4\u6301\u8840\u7ea2\u86cb\u767d\u5728\u76ee\u6807\u6c34\u5e73\u8303\u56f4\u5185\uff0c\u5176\u4e2d\u672a\u63a5\u53d7\u8fc7\u4fc3\u7ea2\u7ec6\u80de\u751f\u6210\u5242\u6cbb\u7597\u60a3\u4e3a\u8fbe\u6807\u6bd4\u4f8b 92.3%\uff0c\u800c\u63a5\u53d7\u8fc7\u7684\u60a3\u8005\u4e3a 74.4%\u3002\u53e6\u4e00\u9879Clin J Am Soc Nephrol\u671f\u520a\u53d1\u8868\u7684\u4e00\u7bc7 2b \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7814\u7a76\u7ed3\u679c\u663e\u793a 145 \u4f8b\u8840\u7ea2\u86cb\u767d \u2264 10.5 g\/dl \u7684\u975e\u900f\u6790 CKD \u60a3\u8005\uff0c\u7ecf\u8fc7\u4e0d\u540c\u7ed9\u836f\u65b9\u6848\u7684 Roxadustat \u6cbb\u7597 16 \u5468\u6216 24 \u5468\uff0c92%\u7684\u60a3\u8005\u83b7\u5f97\u8840\u7ea2\u86cb\u767d\u5e94\u7b54\u3002\u6cbb\u7597 16 \u5468\u540e\uff0c\u94c1\u8c03\u7d20\u6c34\u5e73\u663e\u8457\u964d\u4f4e 16.9%\uff0c\u7f51\u7ec7\u7ea2\u7ec6\u80de\u8840\u7ea2\u86cb\u767d\u542b\u91cf\u65e0\u53d8\u5316\uff0c\u8840\u7ea2\u86cb\u767d\u5e73\u5747\u589e\u52a01.83g\/dl\uff0c\u8bd5\u9a8c\u8fbe\u5230\u9884\u8bbe\u7684\u6cbb\u7597\u7ec8\u70b9\u3002<\/span><\/p>\n<p style=\"text-align: justify;margin-bottom: 10px;\"><span style=\"font-size: 15px;\"><\/span><\/p>\n<p style=\"text-align: center;margin-bottom: 10px;\"><img class=\"\"         style=\"width: 100%;height: auto;\" src=\"http:\/\/www.05921.net\/wp-content\/uploads\/2018\/09\/3-1537925711.jpg\" alt=\"HIF-\u4e8c\u6c27\u9176\u6291\u5236\u5242\u6709\u671b\u8ba9\u80be\u75c5\u7efc\u5408\u5f81\u60a3\u8005\u964d\u4f4e\u5bf9\u4fc3\u7ea2\u7d20\u7684\u4f9d\u8d56\" title=\"HIF-\u4e8c\u6c27\u9176\u6291\u5236\u5242\u6709\u671b\u8ba9\u80be\u75c5\u7efc\u5408\u5f81\u60a3\u8005\u964d\u4f4e\u5bf9\u4fc3\u7ea2\u7d20\u7684\u4f9d\u8d56\"  \/><\/p>\n<p style=\"text-align: justify;margin-bottom: 10px;\"><span style=\"font-size: 15px;\">\u6d41\u884c\u75c5\u5b66\u6570\u636e\u663e\u793a\u4e2d\u56fd\u6162\u6027\u80be\u810f\u75c5\uff08CKD\uff09\u60a3\u8005\u4eba\u6570\u8d85\u8fc7 1 \u4ebf\uff0c\u5176\u4e2d\u8d85\u8fc7 100\u4e07\u60a3\u8005\u662f\u7ec8\u672b\u671f\uff0c\u9700\u8981\u63a5\u53d7\u900f\u6790\u6216\u80be\u79fb\u690d\u6cbb\u7597\uff0c98.2%\u7684\u900f\u6790\u60a3\u8005\u4e3a\u5408\u5e76\u8d2b\u8840\uff0c52.1%\u4e3a\u975e\u900f\u6790\u60a3\u8005\u5408\u5e76\u8d2b\u8840\uff0c\u6cbb\u7597\u836f\u7269\u4e3b\u8981\u662f\u94c1\u5242\u548c\u4fc3\u7ea2\u7d20\uff0c\u4e3b\u8981\u7684\u7ed9\u836f\u65b9\u5f0f\u5747\u4e3a\u6ce8\u5c04\uff0c\u56e0\u6b64\u6709\u53e3\u670d\u7684\u4f18\u52bf\u3002FibroGen \u5df2\u7ecf\u5728 2017 \u5e74 10 \u6708\u5411\u4e2d\u56fd\u63d0\u4ea4\u4e0a\u5e02\u7533\u8bf7\uff0c2018 \u5e74\u6709\u671b\u5728\u7f8e\u56fd\u63d0\u4ea4 NDA\uff0c\u662f 2018 \u5e74\u6700\u503c\u5f97\u5173\u6ce8\u7684\u91cd\u78c5\u4ea7\u54c1\u4e4b\u4e00\uff0c\u79d1\u777f\u552f\u5b89\u9884\u6d4b\u672c\u54c1\u5728 2022 \u5e74\u7684\u9500\u552e\u989d\u53ef\u8fbe 20 \u4ebf\u7f8e\u5143\uff0c\u800cEvalutePharma\u5206\u6790\u5e08\u5219\u9884\u6d4b\u672c\u54c1\u7684\u9500\u552e\u989d\u5cf0\u503c\u53ef\u8fbe58-81\u4ebf\u7f8e\u5143\u3002\u672c\u54c1\u80fd\u5426\u5728 2018 \u5e74\u4e0a\u5e02\uff0c\u8fd9\u5c31\u5f97\u770b CFDA \u7684\u5ba1\u8bc4\u901f\u5ea6\u4e86\u3002<\/span><\/p>\n<p style=\"text-align: justify;margin-bottom: 10px;\"><span style=\"font-size: 15px;\">\u9664\u4e86\u7f57\u6c99\u53f8\u4ed6\uff0c\u4e5f\u6709\u591a\u4e2a\u540c\u9776\u70b9\u836f\u7269\u7d27\u8ddf\u800c\u6765\uff0c\u5904\u5728\u4e09\u671f\u4e34\u5e8a\u7684\u836f\u7269\u5305\u62ecAkebia\u516c\u53f8\u7684Vadadustat\u3001\u548cGSK\u7684Daprodustat\u3002\u4e0d\u96be\u60f3\u8c61\u7684\u662f\uff0c\u672a\u6765\u4fc3\u7ea2\u7d20\u768475\u4ebf\u7f8e\u5143\u5e02\u573a\uff0c\u5373\u5c06\u9762\u4e34<span style=\"font-size: 15px;text-align: justify;\">\u4f4e\u6c27\u8bf1\u5bfc\u56e0\u5b50\u812f\u6c28\u9170\u7f9f\u5316\u9176\u6291\u5236\u5242\u7684\u6311\u6218\u3002<\/span><\/span><\/p>\n<p style=\"text-align: center;margin-bottom: 10px;\"><img class=\"\"         style=\"width: 100%;height: auto;\" src=\"http:\/\/www.05921.net\/wp-content\/uploads\/2018\/09\/0-1537925712.jpg\" alt=\"HIF-\u4e8c\u6c27\u9176\u6291\u5236\u5242\u6709\u671b\u8ba9\u80be\u75c5\u7efc\u5408\u5f81\u60a3\u8005\u964d\u4f4e\u5bf9\u4fc3\u7ea2\u7d20\u7684\u4f9d\u8d56\" title=\"HIF-\u4e8c\u6c27\u9176\u6291\u5236\u5242\u6709\u671b\u8ba9\u80be\u75c5\u7efc\u5408\u5f81\u60a3\u8005\u964d\u4f4e\u5bf9\u4fc3\u7ea2\u7d20\u7684\u4f9d\u8d56\"  \/><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-size: 15px;text-align: justify;\"><\/span><br  \/><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-size: 15px;text-align: justify;\">\u53c2\u8003\u6587\u732e<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-size: 15px;text-align: justify;\"><br  \/><\/span><\/p>\n<p style=\"text-align: left;\"><span style=\"font-size: 12px;\">Astellas pharma. Astellas and FibroGen Announce Positive Topline Results from First Japan Phase 3 Trial for Roxadustat in Chronic Kidney Disease Patients with Anemia. (2017-10-31), [2018-01-05]: https:\/\/www.astellas.com\/en\/news\/9871<\/span><\/p>\n<p style=\"text-align: left;\"><span style=\"font-size: 12px;\">Astellas pharma.&nbsp;Astellas Announces Positive Topline Results for Global Phase 3 Trial of Roxadustat in Chronic Kidney Disease (CKD) Patients with Anemia not on Dialysis\uff1ahttps:\/\/www.astellas.com\/en\/news\/14261<\/span><\/p>\n<p><span style=\"font-size: 12px;\">Provenzano R, Besarab A, Sun CH, Diamond SA et al. Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD. Clinical Journal of the American Society of Nephrology. 2016, 11(6): 982-91.<br  \/><\/span><\/p>\n<p style=\"text-align: left;\"><span style=\"font-size: 12px;\">EvaluatePharma.&nbsp;Roxadustat passes Alps test but has bigger mountains to climb\uff1ahttp:\/\/www.evaluate.com\/vantage\/articles\/news\/trial-results\/roxadustat-passes-alps-test-has-bigger-mountains-climb<\/span><\/p>\n<p style=\"text-align: left;\"><br  \/><\/p>\n<hr style=\"max-width: 100%;color: rgb(51, 51, 51);font-family: -apple-system-font, BlinkMacSystemFont, &quot;Helvetica Neue&quot;, &quot;PingFang SC&quot;, &quot;Hiragino Sans GB&quot;, &quot;Microsoft YaHei UI&quot;, &quot;Microsoft YaHei&quot;, Arial, sans-serif;font-size: 17px;letter-spacing: 0.544px;text-align: justify;white-space: normal;background-color: rgb(255, 255, 255);box-sizing: border-box !important;word-wrap: break-word !important;\"  \/>\n<p style=\"max-width: 100%;min-height: 1em;color: rgb(51, 51, 51);font-family: -apple-system-font, BlinkMacSystemFont, &quot;Helvetica Neue&quot;, &quot;PingFang SC&quot;, &quot;Hiragino Sans GB&quot;, &quot;Microsoft YaHei UI&quot;, &quot;Microsoft YaHei&quot;, Arial, sans-serif;font-size: 17px;letter-spacing: 0.544px;white-space: normal;background-color: rgb(255, 255, 255);text-align: center;box-sizing: border-box !important;word-wrap: break-word !important;\"><span style=\"max-width: 100%;font-size: 15px;letter-spacing: 0.48px;box-sizing: border-box !important;word-wrap: break-word !important;\"><\/span><\/p>\n<p style=\"max-width: 100%;min-height: 1em;color: rgb(51, 51, 51);font-family: -apple-system-font, BlinkMacSystemFont, &quot;Helvetica Neue&quot;, &quot;PingFang SC&quot;, &quot;Hiragino Sans GB&quot;, &quot;Microsoft YaHei UI&quot;, &quot;Microsoft YaHei&quot;, Arial, sans-serif;font-size: 17px;letter-spacing: 0.544px;text-align: justify;white-space: normal;background-color: rgb(255, 255, 255);box-sizing: border-box !important;word-wrap: break-word !important;\"><span style=\"max-width: 100%;font-size: 15px;letter-spacing: 0.48px;box-sizing: border-box !important;word-wrap: break-word !important;\">\u836f\u4e8b\u7eb5\u6a2a\u662f\u4e00\u4e2a\u5f00\u653e\uff0c\u7531\u81ea\u613f\u8005\u7ec4\u6210\u7684\u56e2\u4f53\uff0c\u73b0\u6709\u6210\u545834\u540d\uff0c\u5206\u522b\u4e3aVoyager88\uff0c\u96f7\u8bfa\u5c9b\uff0cHerman\uff0c\u6885\u5e0c\uff0c\u6587\u7af9\uff0cduke\uff0cyhqqqqq\uff0c\u5360\u5c0f\u5175\uff0c\u9526\u5fc3\u7ee3\u53e3\uff0cflydp511\uff0c\u5de7\u5de7\uff0c\u9621\u4e0a\u964c\u964c\uff0c\u591a\u5df4\u80fa\uff0c\u745c\u513f\uff0cKailyn\uff0cSeven\uff0c\u5b50\u708e\uff0c\u514b\u683c\u83ab\uff0cVicky\uff0cSophia \uff0c\u4f9d\u7136\u7279\u96f7\u897f\uff0c\u5076\u9635\u96e8\uff0cAimee\uff0c\u4ed6\u5c71\u4e4b\u77f3\uff0c\u96f6\u4e0b274\u2103\uff0cBreathless\uff0cLuffy\uff0c\u80e1\u4e0d\u559c\uff0c&nbsp;Helen\uff0c\u7b49\u7b49\uff0cSUNRISE\uff0cZMJ\uff0c\u6da6\u513f\uff0cJessie\u3002\u6b22\u8fce\u6709\u5fd7\u4e4b\u58eb\u52a0\u5165\u6211\u4eec\u56e2\u961f\u3002\u6295\u7a3f\u3001\u5408\u4f5c\u3001\u52a0\u4e13\u4e1a\u7fa4\u8bf7\u52a0\u5fae\u4fe1442015666\uff0c\u836f\u4e8b\u7eb5\u6a2a\u4e8c\u5343\u4ebaQQ\u7fa422711855\u3002<\/span><\/p>\n<p><br  \/><\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u8fd1\u65e5\uff0c\u5b89\u65af\u6cf0\u6765\u516c\u544a\u79f0\u5176\u5728\u7814\u65b0\u836fRoxadustat\uff08\u7f57\u6c99\u53f8\u4ed6\uff09\u5728\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u8fbe\u5230\u4e3b\u8981\u7ec8\u70b9\uff0c\u524d24\u5468\u300128\u5468\u548c [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":47017,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/47016"}],"collection":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/comments?post=47016"}],"version-history":[{"count":1,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/47016\/revisions"}],"predecessor-version":[{"id":47020,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/47016\/revisions\/47020"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/media\/47017"}],"wp:attachment":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/media?parent=47016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/categories?post=47016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/tags?post=47016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}